A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
Pfizer is in discussions with the Indian government seeking an “expedited approval pathway” for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
“Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” he said.
“We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country.”
Our Standards: The Thomson Reuters Trust Principles.
HALIFAX, NOVA SCOTIA — As Halifax confronts one of the most pressing housing shortages in…
PARIS, FRANCE — Servair, a member of gategroup, is once again reaching for the stars.…
Sale hailed as major sign of confidence in city’s real estate market and security in UAE …
By Daniel Welinder, Head of Aircraft Management and Sales at Jet Agent The acquisition of…
COPENHAGEN, DENMARK — DeCarbon Copenhagen 2026 will convene Europe’s biomass, carbon markets and digital infrastructure…
LONDON, UNITED KINGDOM — Parabellum Investments has announced the sale of business process outsourcing (BPO)…